Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07533357) titled 'Tpex Subsets in Negative Tumor Draining Lymph Nodes for Predicting the Efficacy of PD 1 Inhibitors in Advanced or Recurrent Esophageal Squamous Cell Carcinoma' on April 5.
Study Type: Observational
Primary Sponsor: Fudan University
Condition:
Esophageal Cancer
Recruitment Status: Not recruiting
Date of First Enrollment: April 20, 2026
Target Sample Size: 158
To know more, visit https://clinicaltrials.gov/study/NCT07533357
Published by HT Digital Content Services with permission from Health Daily Digest....